欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/5799/002
药品名称Levodopa/Carbidopa STADA 200 mg/50 mg Retardtabletten
活性成分
    • cabidopa (as monohydrate) 25.0 mg
    • levodopa carbidopa (as monohydrate) 100.0 mg
剂型Modified-release tablet
上市许可持有人STADAPHARM GmbH Stadastrasse 2-18 61118 Bad Vilbel Germany
参考成员国 - 产品名称Germany (DE)
Levodopa/Carbidopa STADA 200 mg/50 mg Retardtabletten
互认成员国 - 产品名称
    • Austria (AT)
      Levodopa / Carbidopa retard 200/50 mg Stada Retardkapseln
许可日期2008/04/05
最近更新日期2024/08/13
药物ATC编码
    • N04BA02 levodopa and decarboxylase inhibitor
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:[not specified]
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase